Current evidence suggests that the persistent sympathetic nerve activity (SNA), commonly observed following exposure to hypoxia (HX), is mediated by chemoreceptor sensitization and or baroreflex resetting. Evidence in humans and animals suggests that these reflexes may independently regulate the frequency (gating) and amplitude (neuronal recruitment) of SNA bursts. In humans (n=7), we examined the regulation of SNA following acute isocapnic HX (5 min; end-tidal PO 2 = 45 Torr) and euoxic hypercapnia (HC; 5 min; end-tidal PCO 2 = +10 from baseline). HX increased SNA burst frequency (21±7 to 28±8 Burst/min, P<0.05) and amplitude (99±10 to 125±19 au, P<0.05) as did HC (14±6 to 22±10 bursts/min, P<0.05 and 100±12 to 133±29 au, P<0.05 respectively).
INTRODUCTION
Persistent sympathetic activation has been noted following peripheral chemoreflex activation and typically (6, 10, 23, 26, 27, 42, 44) , but not always (30) , remains elevated for a duration which exceeds the previous stimulus period. Previous research has demonstrated that this persistent activity is related specifically to hypoxia but not hypercapnia (44) . It has also been demonstrated that hyperoxia, administered immediately following hypoxia normalizes sympathetic nerve activity (SNA), suggesting a mechanism related to sensitization of peripheral chemoreceptors and/or central nuclei within the chemoreflex loop (26, 44) . Recently, Queirdo et al. also demonstrated a potential interaction between peripheral chemoreceptor stimulation and baroreflex resetting, such that SNA burst frequency was elevated for a given diastolic pressure (27) .
These data have important implications for understanding the sympatho-excitation commonly observed in hypoxia related disorders (e.g. sleep apnoea syndrome, chronic obstructive pulmonary disease, etc). However, a salient feature of data from many previous studies investigating this phenomenon is that SNA burst frequency remains relatively constant following hypoxia (23, 26, 27, 42, 44) despite a concurrent reduction in ventilation back to pre-hypoxic levels. This presents a conflicting argument: If heightened peripheral chemosensitivity or augmented central processing of chemoreceptor afferent signaling are primary mechanisms leading to persistent SNA, then SNA should be higher during hypoxia compared to during recovery. As this is not case, it remains to be explained by what mechanisms sympathetic activity remains augmented after the removal of the stimulus.
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We posited that this apparent discrepancy may be explained by previously unquantified aspects of sympathetic regulation. Analysis of SNA typically focuses on changes in the frequency or occurrence of bursts, and largely overlooks changes in burst amplitude. In the same individual, burst frequency is highly repeatable between tests, whereas burst amplitude is highly variable due to electrode positioning and the number of active axons contributing to the signal. However, within a given experiment or intervention, burst amplitude remains a robust measure of SNA, providing additional valuable information regarding neuronal activation and recruitment (38) . In fact, burst amplitude has been shown to be more sensitive than frequency at discriminating between certain hyper-sympathetic disorders (40, 41) .
Previously, we demonstrated that hypoxia causes not only an increase in SNA burst frequency but also a significant increase in SNA burst amplitude (39) . We have also recently demonstrated that the frequency of neuronal discharge and the recruitment of sympathetic neurons differs between baroreflex (31) and chemoreflex (38) activation in humans. Therefore, this study tested the hypothesis that SNA burst frequency and amplitude are regulated differentially such that both are augmented during hypoxia, with heightened burst frequency but not amplitude persisting following hypoxia. This scenario would satisfy the above-stated conflicting argument. To test this hypothesis, we performed a post-hoc analysis of previously collected data (39) . The current manuscript focuses on the novel aspect of post-hypoxic persistence of SNA and the differential regulation of sympathetic burst frequency and amplitude in humans.
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METHODS
In a retroactive approach, sympathetic nerve activity data were analyzed in subset of 7 young (27±5 yrs) healthy participants (3 male and 4 female) who participated as part of a larger study (39) . All subjects provided written informed consent prior to taking part in the larger study. A pre-study questionnaire indicated that all participants were nonsmokers, had no confounding respiratory, cardiovascular or neurological diseases or disorders and female participants were using oral contraceptives. All experimental procedures were approved by the Health Sciences Research Ethics Board at The University of Western Ontario in accord with the Declaration of Helsinki.
Experimental Methods
The experimental protocol utilized has been described previously (39) . Briefly, After instrumentation and an initial period of 10 min of quiet rest, baseline measures were collected for an additional 10 min. This was followed by a step decrease in PetO 2 to 45 Torr (~80% arterial oxygen saturation), while PetCO 2 was held constant at baseline levels (dynamic end-tidal gas forcing, (28, 29) ). This level of isocapnic hypoxia was maintained for 5 min, and followed by a step return to normoxia for an additional 10 minutes of recovery.
Data were also analyzed from 5 subjects who were exposed to 5 min of isooxic hypercapnia. After 10 min of baseline measures, PetCO 2 was elevated +10 Torr above Differential Sympathetic Regulation in Humans 7/21 each subject's resting PetCO 2 . PetO 2 was maintained at euoxic levels. The hypercapnic exposure was maintained for 5 minutes, followed by 10 minutes of recovery.
Data Analysis
Cardiovascular, respiratory, and sympathetic data were averaged over 1 min periods immediately preceding hypoxia, during the last minute of the hypoxic challenge, and 10 minutes post-hypoxia. SNA bursts were identified as exhibiting pulse synchrony, having an amplitude two times the previous inter-burst period and having characteristic rising and falling slopes. Burst occurrence was confirmed by visually inspecting the corresponding raw neurogram. SNA was quantified as burst frequency (busts/min), burst occurrence (bursts/100 heart beats) and normalized burst amplitude (% of baseline).
Statistical Analysis
Differences across time were assessed using repeated measures ANOVAs, data with a non-normal distribution were assessed using repeated measures ANOVA on ranks. In the case of main effects, Tukey's post-hoc procedure for multiple comparisons was performed (SigmaStat, v3.11, Systat Software, Inc). Effect sizes for relevant variables were calculated using Cohen's d. Relationships between variables were examined using Pearson correlations. With all analyses, statistical significance was defined at P < 0.05.
Data are expressed as means ± SD.
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RESULTS
A complete analysis of the cardio-respiratory effects of hypoxia and hypercapnia has been published previously (39) . Relevant cardio-respiratory responses preceding, during, and following each condition are shown in Tables 1 and 2. Hypoxia was associated with an expected rise in VE (12.2 ± 2.5 to 28.1 ± 7.4 L/min, P<0.05), an elevated HR (59 ± 7 to 79 ± 10 bpm, P<0.05) and a modest pressor response, evident by a rise in SBP (122 ± 12 to 132 ± 11 mmHg, P<0.05) and MAP (92 ± 9 to 98 ± 9 mmHg, P<0.05) (but not DBP). As described previously, hypoxia was also associated with an elevated sympathetic activation. Both SNA burst frequency (21 ± 7 to 28 ± 8 Compared to hypoxia, hypercapnia resulted in a similar increase in VE but a more robust pressor response (Table 2 ). In this subset of participants, hypercapnia was also associated with an increase in SNA burst frequency (14 ± 6 to 22 ± 10 bursts/min, P<0.05) and normalized amplitude (100 ± 12 to 133 ± 29 au, P<0.05). With the termination of hypercapnia, both VE and MAP normalized to pre-hypercapnic values.
Both SNA burst frequency and amplitude decreased during recovery -although burst frequency tended to remain elevated above baseline values (19 ± 8 Bursts/min, P = 0.07).
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DISCUSSION
The data from the current study identify three novel and important aspects of sympathetic regulation in humans: 1) the differential regulation of frequency and amplitude in humans, 2) hypoxia is associated with a post-stimulus potentiation of sympathetic burst frequency but not burst amplitude and 3) the amplitude response, but not the frequency response, appears related to peripheral chemoreceptor activation.
Evidence for Differential Regulation of Sympathetic Activity
There is clear evidence in anaesthetized cats and rabbits to suggest that SNA burst frequency and amplitude are regulated independently and differently in response to baroreflex and chemoreflex activation (17) (18) (19) (20) . The data from the present study highlight the differential regulation of sympathetic burst frequency and amplitude in response to chemoreflex stress in humans. These observations are supported by our recent work demonstrating that neuronal discharge frequency and the recruitment of sympathetic neurons differs between baroreflex (31) and chemoreflex (38) stressors, and previous data suggesting different frequency and amplitude activation between baroreceptor and nociceptor challenges (14, 32) . A reinterpretation of previously published data also suggests differential contributions of sympathetic burst frequency and amplitude during and following reflex sympathetic activation by hypoxia. The increase in total SNA during, and the subsequent decline following asphyxia appears greater than that explained by frequency alone (23) , whereas data from the same group and others indicate a significant increase in burst frequency, but not burst amplitude, during and following isocapnic hypoxia (26, 44) . Further, differential regulation and adaptation of mechanisms Differential Sympathetic Regulation in Humans 11/21 associated with burst frequency and amplitude is suggested by an augmented burst frequency (but not amplitude) response to acute hypoxia following 10 days of periodic hypoxia (15) .
Mechanisms Contributing to Differential Sympathetic Regulation: Chemoreflex Sensitization
Heightened sensitivity of the chemoreflex pathway has been proposed as a mechanism that contributes to the prolonged recovery of sympathetic outflow following hypoxia (26, 27) . This is supported by recent data demonstrating that the persistent sympathetic activity following hypoxia (23, 26, 27, 42, 44) (but not hypercapnia (44)) can be suppressed by the administration of hyperoxia (26) . However, in vivo studies directly measuring carotid body activity have shown that carotid sinus nerve activity in fact returns to normal immediately following various paradigms of acute hypoxia (2, 25) .
Furthermore, peripheral chemoreceptor activity drives the ventilatory response to hypoxia which is not sustained following the removal of the hypoxic stimulus (26, 27, 42, 44) . In keeping with this premise, using ventilation as an indicator of peripheral chemoreceptor activation, we observed a strong correlation with burst amplitude. These data suggest that the peripheral chemoreflex activation plays an important role in sympathetic neural recruitment. Importantly, we have previously demonstrated that chemoreflex activation, and not ventilation per se, is linked to augmented burst amplitude (35) . In contrast, the current data show no relationship between the increase in ventilation and burst frequency in response to hypoxia. These data suggest that mechanisms other than peripheral Differential Sympathetic Regulation in Humans 12/21 chemoreflex sensitization cause post-stimulus persistence of sympathetic burst frequency following acute hypoxia.
Mechanisms Contributing to Differential Sympathetic Regulation: Baroreflex Resetting
Chemoreflex stimulation increases efferent sympathetic activity through an increase in neuronal firing rate (16) and recruitment of additional sympathetic neurons (38) .
Despite the differential regulation of sympathetic burst frequency and amplitude, it is evident that some form of hypoxia related sensitization occurs, resulting in augmented sympathetic burst frequency following hypoxia. An interaction exists between chemoreflex and baroreflex pathways that control sympathetic activity in humans (8, 9, 22, 27, 34) and other mammals (12, 13) . Furthermore, sympathetic baroreflex resetting occurs during (12, 13, 22, 27) and following (22, 27) hypoxia, which promotes an elevated sympathetic burst frequency. This proposal is consistent with the model proposed by Kienbaum et al. (14) who suggest the baroreflex primarily modulates sympathetic burst frequency and not amplitude. This is also supported by our data which demonstrate a strong correlation between metrics of chemoreflex engagement (i.e. ventilation) and burst amplitude, but not frequency, as well as a persistence in sympathetic burst frequency, but not amplitude, following the removal hypoxia.
Although the specific mechanisms resulting in hypoxia-mediated baroreflex resetting have not been identified, the inhibition of baro-activated neurons within the caudal ventro-lateral medulla (CVLM) (21) , in conjunction with a sensitization of glutamatergic neurons within the rostral ventro-lateral medulla (RVLM) (33), may play a role.
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Based on available information, the role of the peripheral chemoreceptors appears to be that of an obligatory input, regulating the level of background sympathetic activity (amplitude) which is subsequently gated by the baroreflex. A reset baroreflex that persists in the recovery period would sustain an elevated burst frequency. As the baroreflex exerts little influence on burst amplitude, this feature of the neurogram would return to baseline levels once the hypoxic stimulus is removed. This model serves to explain augmented sympathetic burst frequency during and following hypoxia, as well as the depressive influence of hyperoxia (removal of peripheral chemoreceptor input) on persistent SNA following hypoxia (26) .
Methodological Considerations
An important consideration in the current study is the duration and type of hypoxic stimulus. Here we used a 5 min exposure to isocapnic hypoxia, whereas previous investigations have typically used longer exposures ranging from 20 min (23, 26, 27, 42, 44 ) to 4 weeks (10) of hypercapnic (23, 42) , isocapnic (26, 27, 44) , or poikilocapnic (i.e. hypocapnic) (10, 30, 42) hypoxia. There are two important strengths of the experimental paradigm used in the current study. Firstly, an isocapnic perturbation avoids the known effects of CO 2 (both hyper-and hypocapnic) on ventilatory, cardiovascular and sympathetic responses to hypoxia (36, 37, 42, 43) . Secondly, using ventilation as a surrogate marker of peripheral chemoreflex engagement, we know that peak ventilation occurs within the first 5 min of hypoxia. Thereafter the phenomenon of hypoxic ventilatory decline (HVD) occurs. The current hypothesis is that the peripheral chemoreceptors and associated neural pathways play a pivotal role in these responses Differential Sympathetic Regulation in Humans 14/21 (43) . As such, a 5 min perturbation allows for the determination of the peak response to peripheral chemoreflex activation while seeking to avoid the adaptive mechanisms associated with HVD. Based on these previous data we expect that extended exposure to hypoxia may result in differing patterns of sympathetic engagement and persistence, and that additional studies are necessary to address this further.
Perspectives and Significance
The interpretation of physiology depends upon appropriate analysis of data. There There are also implications for pathological scenarios as well. For example, resetting of the sympathetic baroreflex is observed in many clinical manifestations of hypoxia (e.g. obstructive sleep apnea, chronic obstructive pulmonary disease, heart failure, etc) (1, 5, 11, 24) . It has been suggested that chemoreflex activation may be one mechanism leading to this resetting (4) . Moreover, although previous data suggest that acute hypoxia does not cause an increase in basal chemoreceptor activity (2), prolonged bouts of continuous or intermittent hypoxia may (25) . As such, a simultaneous sensitization of the chemoreflex and resetting of the baroreflex may explain augmented sympathetic burst frequency as well as burst amplitude (40, 41) in these populations.
In this study we have demonstrated differential regulation of burst frequency and amplitude in integrated recordings of muscle sympathetic nerve activity in humans. 
